ReviewInternational journal of molecular sciences2024

Navigating the Complement Pathway to Optimize PNH Treatment with Pegcetacoplan and Other Currently Approved Complement Inhibitors.

Peter Hillmen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.